Literature DB >> 7944341

Catalytic activity of anti-ground state antibodies, antibody subunits, and human autoantibodies.

S Paul1.   

Abstract

Catalytic antibodies may be produced over the natural course of antibody-affinity maturation by placement of chemically reactive residues in antibody-active sites by somatic hypermutation or V-D-J-gene rearrangement. This hypothesis has received support from recent observations on the chemical reactivity of antibodies to vasoactive intestinal peptide (VIP), DNA, and steroid- and dinitrophenyl-esters. Recent studies reveal that monoclonal antibodies raised against the ground state of VIP can accelerate the cleavage of peptide bonds. The light-chain (L-chain) subunit of human autoantibodies display increased hydrolytic rate and diminished VIP-binding affinity compared to the parent antibody, consistent with increased turnover owing to weaker binding of the substrate ground state. These observations reveal an essential limitation of catalytic antibodies, i.e., large turnover rates may be associated with diminished substrate specificity. The hydrolysis of VIP by IgG purified by affinity chromatography from asthma patients and nonasthmatic controls was compared. IgG from the majority of asthma patients displayed VIP-hydrolyzing activity. Vmax values for IgG from asthmatics tended to be higher than those from the nonasthmatic group. In principle, catalysis by antibodies may be an important mediator of immunological defense, regulation, and autoimmune dysfunction. The verification of these possibilities will require studies that utilize efficient assays of antibody catalysis during experimental immunization and autoimmune disease, as well as mechanistic investigation of catalysis by antibodies and their subunits.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944341     DOI: 10.1007/bf02787938

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  30 in total

1.  At the crossroads of chemistry and immunology: catalytic antibodies.

Authors:  R A Lerner; S J Benkovic; P G Schultz
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

Review 2.  VIP as a modulator of lung inflammation and airway constriction.

Authors:  S I Said
Journal:  Am Rev Respir Dis       Date:  1991-03

Review 3.  Antibody-antigen complexes.

Authors:  D R Davies; E A Padlan; S Sheriff
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

Review 4.  Influence of neuropeptides on airway smooth muscle.

Authors:  S I Said
Journal:  Am Rev Respir Dis       Date:  1987-12

5.  DNA hydrolyzing autoantibodies.

Authors:  A M Shuster; G V Gololobov; O A Kvashuk; A E Bogomolova; I V Smirnov; A G Gabibov
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

6.  Catalytic antibodies.

Authors:  A Tramontano; K D Janda; R A Lerner
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

7.  Do immunoglobulins have proteolytic activity?

Authors:  S Erhan; L D Greller
Journal:  Nature       Date:  1974-09-27       Impact factor: 49.962

8.  Monoclonal immunoglobulin G augments hydrolysis of an ester of the homologous hapten: an esterase-like activity of the antibody-containing site?

Authors:  F Kohen; J B Kim; H R Lindner; Z Eshhar; B Green
Journal:  FEBS Lett       Date:  1980-03-10       Impact factor: 4.124

9.  Effects of immunization against VIP on neurotransmission in cat trachea.

Authors:  H Hakoda; Z Q Xie; H Aizawa; H Inoue; M Hirata; Y Ito
Journal:  Am J Physiol       Date:  1991-10

10.  Framework peptides from kappa IIIb rheumatoid factor light chains with binding activity for aggregated IgG.

Authors:  F C Hay; A J Soltys; G Tribbick; H M Geysen
Journal:  Eur J Immunol       Date:  1991-08       Impact factor: 5.532

View more
  3 in total

1.  Natural antibody catalytic activities in mice with autoimmune disorders.

Authors:  N A Ponomarenko; E S Aleksandrova; I I Vorobiev; O M Durova; A V Kozyr; A V Kolesnikov; G B Telegin; A R Kalinina; S V Suchkov; A G Gabibov
Journal:  Dokl Biochem       Date:  2000 Nov-Dec

2.  On the catalytic activity of autoantibodies in multiple sclerosis.

Authors:  N A Ponomarenko; O M Durova; I I Vorob'ev; S V Suchkov; A G Gabibov
Journal:  Dokl Biochem Biophys       Date:  2004 Mar-Apr       Impact factor: 0.788

Review 3.  Natural catalytic antibodies.

Authors:  S Paul
Journal:  Mol Biotechnol       Date:  1996-06       Impact factor: 2.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.